Metraipolis › archive › dc_560ff53750e6

Real-world adverse event profiles of Zuranolone and Brexanolone based on FAERS and VigiAccess databases: An observational study — Europe PMC PMID:42470061

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42470061
DOI
10.1097/md.0000000000049845
License (as archived)
solo-consultazione
Archived
2026-10-08T01:27:35.818Z
SHA-256 of the archived text
bbbdfb9638cd08c899a4fc50a01b37e5feb42fe98d8a225b0ff0f12b78a838b8
Stable URL of this page
https://metraipolis.com/documento/dc_560ff53750e6

How to cite

Real-world adverse event profiles of Zuranolone and Brexanolone based on FAERS and VigiAccess databases: An observational study — Europe PMC PMID:42470061 — Europe PMC (en), https://europepmc.org/article/MED/42470061 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_560ff53750e6 (Metraipolis archive dc_560ff53750e6, sha256 bbbdfb9638cd08c899a4fc50a01b37e5feb42fe98d8a225b0ff0f12b78a838b8)
BibTeX
@misc{dc560ff53750e6,
  title = {Real-world adverse event profiles of Zuranolone and Brexanolone based on FAERS and VigiAccess databases: An observational study — Europe PMC PMID:42470061},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42470061},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_560ff53750e6; sha256 bbbdfb9638cd08c899a4fc50a01b37e5feb42fe98d8a225b0ff0f12b78a838b8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42470061. Agents can read the archived copy with the MCP tool read_document.